Total planned funding: $121,508,686
Allocations
Countries/Regions
India | $121,508,686 |
Organizational Types
Unknown | $54,019,374 |
NGO | $33,388,110 |
Own Agency | $18,425,999 |
University | $9,541,895 |
Multi-lateral Agency | $2,406,808 |
Private Contractor | $1,659,000 |
FBO | $1,100,000 |
Other USG Agency | $627,300 |
Host Country Government Agency | $340,200 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $43,922,467 |
Prevention | $31,416,632 |
Care | $14,526,501 |
Management and Operations | $13,409,911 |
Testing | $7,033,627 |
Treatment | $6,771,756 |
Budget Codes
OHSS: Health Systems Strengthening | $24,655,022 |
HVOP: Sexual Prevention: Other Sexual Prevention | $16,482,567 |
HVSI: Strategic Information | $15,684,753 |
HVMS: Management and Operations | $13,409,911 |
HBHC: Care: Adult Care and Support | $9,792,620 |
HVCT: Testing: HIV Testing and Counseling | $7,033,627 |
HTXS: Treatment: Adult Treatment | $6,458,485 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,268,944 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,278,425 |
HLAB: Laboratory Infrastructure | $3,582,692 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,336,455 |
HKID: Care: Orphans and Vulnerable Children | $2,533,898 |
HVTB: Care: TB/HIV | $1,908,693 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDCS: Care: Pediatric Care and Support | $291,290 |
PDTX: Treatment: Pediatric Treatment | $289,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$53,394,885
Countries/Regions
FHI 360:
$15,090,357
Countries/Regions
USG Aggregated Agencies:
$8,734,794
Countries/Regions
Voluntary Health Services:
$5,750,000
Countries/Regions